within Pharmacolibrary.Drugs.N_NervousSystem.N05C_HypnoticsAndSedatives.N05CM05_Scopolamine;

model Scopolamine
  extends Pharmacolibrary.Drugs.ATC.N.N05CM05;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>N05CM05</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Scopolamine is an anticholinergic agent used to prevent nausea and vomiting caused by motion sickness or anesthesia and surgery. It acts as a competitive antagonist of muscarinic acetylcholine receptors. Scopolamine is approved and used today, commonly administered via transdermal patches or other parenteral routes.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after intravenous administration.</p><h4>References</h4><ol><li><p>Renner, UD, Oertel, R, &amp; Kirch, W (2005). Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. <i>Therapeutic drug monitoring</i> 27(5) 655–665. DOI:<a href=\"https://doi.org/10.1097/01.ftd.0000168293.48226.57\">10.1097/01.ftd.0000168293.48226.57</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16175141/\">https://pubmed.ncbi.nlm.nih.gov/16175141</a></p></li><li><p>Putcha, L, Cintrón, NM, Tsui, J, Vanderploeg, JM, &amp; Kramer, WG (1989). Pharmacokinetics and oral bioavailability of scopolamine in normal subjects. <i>Pharmaceutical research</i> 6(6) 481–485. DOI:<a href=\"https://doi.org/10.1023/a:1015916423156\">10.1023/a:1015916423156</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2762223/\">https://pubmed.ncbi.nlm.nih.gov/2762223</a></p></li><li><p>Nachum, Z, Shupak, A, &amp; Gordon, CR (2006). Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications. <i>Clinical pharmacokinetics</i> 45(6) 543–566. DOI:<a href=\"https://doi.org/10.2165/00003088-200645060-00001\">10.2165/00003088-200645060-00001</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16719539/\">https://pubmed.ncbi.nlm.nih.gov/16719539</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Scopolamine;
